Display options
Cite
Ikai A, Ookata K, Shimizu M, et al. A recombinant bait region mutant of human alpha2-macroglobulin exhibiting an altered proteinase-inhibiting spectrum. Cytotechnology. 1999;31(1):53-60doi: 10.1023/A:1008011919876.
Ikai, A., Ookata, K., Shimizu, M., Nakamichi, N., Ito, M., & Matsumura, T. (1999). A recombinant bait region mutant of human alpha2-macroglobulin exhibiting an altered proteinase-inhibiting spectrum. Cytotechnology, 31(1), 53-60. https://doi.org/10.1023/A:1008011919876
Ikai, A, et al. "A recombinant bait region mutant of human alpha2-macroglobulin exhibiting an altered proteinase-inhibiting spectrum." Cytotechnology vol. 31,1 (1999): 53-60. doi: https://doi.org/10.1023/A:1008011919876
Ikai A, Ookata K, Shimizu M, Nakamichi N, Ito M, Matsumura T. A recombinant bait region mutant of human alpha2-macroglobulin exhibiting an altered proteinase-inhibiting spectrum. Cytotechnology. 1999 Sep;31(1):53-60. doi: 10.1023/A:1008011919876. PMID: 19003124; PMCID: PMC3449781.
Copy Download .nbib Format: NLM
Share it on

Cytotechnology. 1999 Sep;31(1):53-60. doi: 10.1023/A:1008011919876.

A recombinant bait region mutant of human alpha2-macroglobulin exhibiting an altered proteinase-inhibiting spectrum.

Cytotechnology

A Ikai, K Ookata, M Shimizu, N Nakamichi, M Ito, T Matsumura

PMID: 19003124 PMCID: PMC3449781 DOI: 10.1023/A:1008011919876

Abstract

Alpha 2-macroglobulin (alpha2M), a plasma glycoprotein produced in the liver, inhibits a variety of proteinases and thus considered to play important homeostatic roles in the body. This broad inhibitory spectrum has been explained by the trapping theory by which a proteinase recognizes a region of 25-30 amino acid peptide in alpha2M called bait region and cleaves it, leading to the conformational change of alpha2M, and to the subsequent entrapment and inhibition of the proteinase. We constructed alpha2M cDNAs with mutated DNA sequences in the bait region, and obtained recombinant CHO cell lines producing either wild type alpha2M, or mutant alpha2Ms, i.e., alpha2M/K692 and alpha2M/K696, each with substitution of Arg with Lys at codons 692 and 696, respectively. We tested if lysyl endopeptidase is not inhibited by wild type alpha2M, but could be inhibited by these engineered mutant alpha2Ms. Thus, recombinant alpha2M/K696 protein successfully inhibited lysyl endopeptidase activity, while recombinant alpha2M/K692 protein was not sensitive to lysyl endopeptidase, suggesting that not all bait region peptide bonds can equally be accessible and susceptible to proteinases. The present results not only provided the trapping theory with additional supportive evidence, but the first experimental evidence for the value of engineered alpha2M-derived proteinase inhibitor with an artificial proteinase inhibitory spectrum of potential industrial and/or therapeutic usefulness.

References

  1. J Biochem. 1987 Jan;101(1):199-205 - PubMed
  2. Zentralbl Bakteriol. 1992 Jul;277(2):145-60 - PubMed
  3. Anal Biochem. 1986 Feb 1;152(2):232-8 - PubMed
  4. Virology. 1993 Apr;193(2):974-6 - PubMed
  5. J Ultrastruct Mol Struct Res. 1986 Jul-Sep;96(1-3):136-45 - PubMed
  6. Biochem Biophys Res Commun. 1984 Jan 30;118(2):691-5 - PubMed
  7. Exp Cell Res. 1994 Mar;211(1):90-8 - PubMed
  8. Zentralbl Bakteriol. 1991 Dec;276(1):16-26 - PubMed
  9. J Bacteriol. 1987 Aug;169(8):3691-5 - PubMed
  10. J Cell Biol. 1979 Sep;82(3):614-25 - PubMed
  11. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2282-6 - PubMed
  12. Biochem J. 1982 Jul 1;205(1):91-5 - PubMed
  13. Comp Biochem Physiol B. 1991;98(4):549-53 - PubMed
  14. Biochem Biophys Res Commun. 1982 Aug 31;107(4):1243-51 - PubMed
  15. J Biol Chem. 1989 Jun 15;264(17):9850-8 - PubMed
  16. Cell. 1977 Nov;12(3):609-17 - PubMed
  17. Microb Pathog. 1991 Aug;11(2):137-41 - PubMed
  18. Lab Invest. 1994 Dec;71(6):792-812 - PubMed
  19. Methods Enzymol. 1994;244:126-37 - PubMed
  20. J Biol Chem. 1989 Feb 5;264(4):2350-6 - PubMed
  21. Biochem J. 1979 Aug 1;181(2):401-18 - PubMed
  22. J Biol Chem. 1989 Jan 5;264(1):393-401 - PubMed
  23. Parasitol Res. 1992;78(3):215-21 - PubMed
  24. J Biol Chem. 1994 Jan 7;269(1):599-606 - PubMed
  25. Biochemistry. 1990 May 1;29(17):4081-7 - PubMed
  26. Arch Biochem Biophys. 1986 Feb 1;244(2):447-53 - PubMed
  27. Biochem J. 1973 Aug;133(4):709-24 - PubMed
  28. J Biol Chem. 1989 Sep 25;264(27):15781-9 - PubMed
  29. Immunology. 1986 Mar;57(3):367-71 - PubMed
  30. Biochemistry. 1985 May 7;24(10):2569-75 - PubMed
  31. Biochemistry. 1985 May 21;24(11):2653-60 - PubMed
  32. FASEB J. 1992 Dec;6(15):3345-53 - PubMed
  33. FEBS Lett. 1981 Dec 7;135(2):295-300 - PubMed
  34. Ann N Y Acad Sci. 1983;421:61-8 - PubMed

Publication Types